Ultimately, our findings revealed that GAS5 deficiency exerted weaker competitive binding ability to miR-17-3p to stimulate the downregulation of Ang-2, thus arresting IL-1β-induced NPC apoptosis and ECM degradation. The gene discussed is ANGPT2; the disease is nasopharyngeal carcinoma.